We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Can-Fite BioPharma Ltd.
Health Care · Biotechnology
Structural: nano-cap Israeli biotech with proprietary A3 adenosine receptor platform; dual NASDAQ/TASE listing provides visibility but float is extremely thin.
CF101 NASH readout could be transformative in an underserved indication; A3AR mechanism is differentiated vs. GLP-1 wave; low base market cap means binary upside on a positive trial.
Phase II NASH data historically poor across the industry; cash runway risk for sub-$10M market-cap company; Israeli geopolitical risk premium; dilution via ATM is near-certain.
Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.